Live feed18:15:00·1651dPRReleasevia QuantisnowAgios Presents Mitapivat Long-term Extension Data Demonstrating Durability of Hemoglobin Response and Transfusion Burden Reduction in Adults with Pyruvate Kinase (PK) Deficiency at 63rd ASH Annual Meeting and ExpositionByQuantisnow·Wall Street's wire, on your screen.AGIO· Agios Pharmaceuticals Inc.Health Care
